✦ LIBER ✦

Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment

Book ID: 122075385
Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 96 KB
Volume: 1
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(85)80104-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of cisplatin plus vindesine w

Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Long-Term Survival Results of a Randomiz

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, with Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients with Bladder Cancer

✍ von der Maase, H.; Sengelov, L.; Roberts, J.T.; Ricci, S.; Dogliotti, L.; Oliver 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 35 KB

A prospective, multicentre clinical tria

A prospective, multicentre clinical trial comparing cisplatin plus gemcitabine with cisplatin plus etoposide in patients with locally advanced and metastatic non-small cell lung cancer

✍ Tuncay GOKSEL; Osman Nuri HATIPOGLU; Can OZTURK; Metin GORGUNER; Murat KIYIK; Ug 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Mitomycin C plus vindesine or cisplatin

Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer

✍ Cesare Gridelli; Giuseppe Airoma; Pasquale Incoronato; Rosario Pepe; Giovanni Pa 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 275 KB

Mitomycin C plus vindesine or cisplatin

Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Randomized trial comparing postoperative

Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer

✍ K. M. W. Pisters; M. G. Kris; R. J. Gralla; B. Hilaris; P. M. McCormack; M. S. B 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

This prospective randomized trial was performed to determine whether postoperative chemotherapy with vindesine and cisplatin could lengthen time to progression and overall survival in stage I11 (Tl-3N2MO) non-small cell lung cancer (NSCLC) patients. Seventy-two patients were entered; 36 were randomi